| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 20 | 2023 | 474 | 3.970 |
Why?
|
| Cartilage, Articular | 33 | 2024 | 1100 | 3.870 |
Why?
|
| Scoliosis | 22 | 2024 | 740 | 2.770 |
Why?
|
| Femur | 20 | 2024 | 1308 | 2.580 |
Why?
|
| Glycosaminoglycans | 18 | 2021 | 607 | 1.930 |
Why?
|
| Hip Dislocation | 5 | 2020 | 247 | 1.500 |
Why?
|
| Bone Density | 27 | 2024 | 3551 | 1.430 |
Why?
|
| Tomography, X-Ray Computed | 51 | 2024 | 20555 | 1.400 |
Why?
|
| Fractures, Spontaneous | 4 | 2016 | 231 | 1.350 |
Why?
|
| Spinal Fusion | 14 | 2022 | 1283 | 1.270 |
Why?
|
| Contrast Media | 26 | 2024 | 5310 | 1.240 |
Why?
|
| X-Ray Microtomography | 15 | 2024 | 455 | 1.140 |
Why?
|
| Tensile Strength | 5 | 2011 | 330 | 1.120 |
Why?
|
| Osteotomy | 4 | 2016 | 837 | 1.120 |
Why?
|
| Thoracoplasty | 3 | 2018 | 15 | 1.110 |
Why?
|
| Compressive Strength | 10 | 2019 | 158 | 1.100 |
Why?
|
| Spine | 11 | 2022 | 1118 | 1.070 |
Why?
|
| Osteoarthritis | 12 | 2024 | 1061 | 1.000 |
Why?
|
| Osteolysis | 5 | 2024 | 275 | 0.910 |
Why?
|
| Ioxaglic Acid | 6 | 2017 | 29 | 0.910 |
Why?
|
| Elastic Modulus | 7 | 2019 | 211 | 0.900 |
Why?
|
| Orthopedic Procedures | 7 | 2023 | 1264 | 0.870 |
Why?
|
| Finite Element Analysis | 5 | 2024 | 437 | 0.830 |
Why?
|
| Fracture Healing | 4 | 2023 | 445 | 0.790 |
Why?
|
| Bone Diseases, Metabolic | 7 | 2023 | 409 | 0.780 |
Why?
|
| Metacarpophalangeal Joint | 3 | 2019 | 82 | 0.760 |
Why?
|
| Bone and Bones | 18 | 2024 | 2568 | 0.690 |
Why?
|
| Absorptiometry, Photon | 12 | 2024 | 1737 | 0.680 |
Why?
|
| Bone Neoplasms | 4 | 2024 | 2527 | 0.680 |
Why?
|
| Progeria | 6 | 2020 | 188 | 0.670 |
Why?
|
| Tibia | 7 | 2016 | 1069 | 0.660 |
Why?
|
| Cervical Vertebrae | 4 | 2020 | 981 | 0.650 |
Why?
|
| Ribs | 6 | 2024 | 252 | 0.600 |
Why?
|
| Osteoporosis | 9 | 2024 | 1605 | 0.590 |
Why?
|
| Growth Plate | 5 | 2024 | 274 | 0.570 |
Why?
|
| Menisci, Tibial | 2 | 2017 | 269 | 0.570 |
Why?
|
| Stress, Mechanical | 13 | 2021 | 1674 | 0.560 |
Why?
|
| Biopolymers | 1 | 2018 | 184 | 0.560 |
Why?
|
| Models, Animal | 6 | 2021 | 2112 | 0.560 |
Why?
|
| Respiratory Insufficiency | 3 | 2020 | 1230 | 0.560 |
Why?
|
| Polymers | 6 | 2023 | 1614 | 0.560 |
Why?
|
| Hip Joint | 4 | 2019 | 1013 | 0.550 |
Why?
|
| Cost of Illness | 2 | 2017 | 1935 | 0.540 |
Why?
|
| Fractures, Bone | 6 | 2015 | 2046 | 0.540 |
Why?
|
| Bone Remodeling | 3 | 2016 | 581 | 0.530 |
Why?
|
| Femoral Neoplasms | 1 | 2016 | 83 | 0.520 |
Why?
|
| Thoracic Vertebrae | 4 | 2018 | 596 | 0.510 |
Why?
|
| Metacarpal Bones | 2 | 2018 | 75 | 0.510 |
Why?
|
| Immobilization | 1 | 2016 | 227 | 0.500 |
Why?
|
| Cattle | 14 | 2021 | 3849 | 0.490 |
Why?
|
| Financing, Personal | 1 | 2017 | 309 | 0.480 |
Why?
|
| Iothalamic Acid | 1 | 2014 | 17 | 0.480 |
Why?
|
| Movement | 2 | 2019 | 1478 | 0.480 |
Why?
|
| Whales | 3 | 2009 | 30 | 0.470 |
Why?
|
| Quality of Life | 7 | 2024 | 13355 | 0.470 |
Why?
|
| Spinal Diseases | 4 | 2020 | 564 | 0.460 |
Why?
|
| Lung | 6 | 2018 | 9994 | 0.460 |
Why?
|
| Kyphosis | 2 | 2021 | 237 | 0.440 |
Why?
|
| Acetabulum | 2 | 2020 | 542 | 0.430 |
Why?
|
| Horses | 10 | 2024 | 300 | 0.430 |
Why?
|
| Rabbits | 11 | 2018 | 4779 | 0.430 |
Why?
|
| Patella | 2 | 2014 | 314 | 0.420 |
Why?
|
| Mobility Limitation | 2 | 2018 | 408 | 0.410 |
Why?
|
| Child | 55 | 2024 | 80156 | 0.400 |
Why?
|
| Caregivers | 4 | 2023 | 2235 | 0.400 |
Why?
|
| Tantalum | 3 | 2023 | 54 | 0.390 |
Why?
|
| Physical Stimulation | 3 | 2016 | 518 | 0.390 |
Why?
|
| Animals | 65 | 2024 | 168388 | 0.370 |
Why?
|
| Neuromuscular Diseases | 3 | 2024 | 257 | 0.360 |
Why?
|
| Nanotechnology | 3 | 2020 | 712 | 0.360 |
Why?
|
| Cadaver | 6 | 2019 | 1358 | 0.360 |
Why?
|
| Chondrocytes | 6 | 2022 | 795 | 0.360 |
Why?
|
| Braces | 2 | 2005 | 138 | 0.350 |
Why?
|
| Disabled Children | 3 | 2017 | 251 | 0.350 |
Why?
|
| Oxides | 3 | 2023 | 401 | 0.340 |
Why?
|
| Syringomyelia | 2 | 2021 | 67 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2024 | 8166 | 0.340 |
Why?
|
| Hip | 3 | 2020 | 255 | 0.330 |
Why?
|
| Female | 91 | 2024 | 392485 | 0.330 |
Why?
|
| Adolescent | 42 | 2024 | 88305 | 0.320 |
Why?
|
| Disability Evaluation | 4 | 2018 | 1836 | 0.320 |
Why?
|
| Orthopedics | 1 | 2017 | 897 | 0.320 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2021 | 158 | 0.310 |
Why?
|
| Fractures, Ununited | 1 | 2010 | 175 | 0.310 |
Why?
|
| Bone Development | 3 | 2021 | 472 | 0.300 |
Why?
|
| Tissue Preservation | 1 | 2008 | 174 | 0.300 |
Why?
|
| Fracture Fixation | 5 | 2012 | 364 | 0.300 |
Why?
|
| Humans | 127 | 2024 | 761326 | 0.290 |
Why?
|
| Femoral Fractures | 2 | 2013 | 375 | 0.290 |
Why?
|
| Lubricants | 2 | 2020 | 26 | 0.280 |
Why?
|
| Male | 76 | 2024 | 360621 | 0.280 |
Why?
|
| Rotation | 4 | 2016 | 517 | 0.280 |
Why?
|
| Gadolinium | 2 | 2015 | 960 | 0.280 |
Why?
|
| Iodobenzenes | 2 | 2017 | 23 | 0.280 |
Why?
|
| Ovariectomy | 5 | 2024 | 614 | 0.280 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 1525 | 0.270 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2022 | 258 | 0.270 |
Why?
|
| Ethylenediamines | 2 | 2017 | 57 | 0.270 |
Why?
|
| Child, Preschool | 27 | 2024 | 42251 | 0.270 |
Why?
|
| Rats | 14 | 2024 | 23729 | 0.270 |
Why?
|
| Osteoarthritis, Knee | 3 | 2020 | 1243 | 0.270 |
Why?
|
| Polyenes | 2 | 2018 | 68 | 0.270 |
Why?
|
| Ultrasonography | 1 | 2019 | 5970 | 0.260 |
Why?
|
| Weight-Bearing | 4 | 2016 | 532 | 0.260 |
Why?
|
| Humeral Fractures | 3 | 2018 | 282 | 0.260 |
Why?
|
| Subtraction Technique | 1 | 2008 | 512 | 0.250 |
Why?
|
| Models, Biological | 6 | 2024 | 9468 | 0.250 |
Why?
|
| Lubrication | 3 | 2023 | 21 | 0.250 |
Why?
|
| Phantoms, Imaging | 6 | 2024 | 2524 | 0.250 |
Why?
|
| Dendrimers | 2 | 2020 | 72 | 0.250 |
Why?
|
| Cartilage Diseases | 1 | 2006 | 157 | 0.240 |
Why?
|
| Radiography | 13 | 2024 | 6966 | 0.240 |
Why?
|
| Titanium | 3 | 2015 | 484 | 0.240 |
Why?
|
| Viscosupplementation | 1 | 2024 | 2 | 0.240 |
Why?
|
| Furans | 2 | 2018 | 200 | 0.240 |
Why?
|
| Health Expenditures | 1 | 2017 | 2365 | 0.240 |
Why?
|
| Cations | 7 | 2024 | 238 | 0.230 |
Why?
|
| Prosthesis Failure | 2 | 2009 | 1204 | 0.230 |
Why?
|
| Specimen Handling | 1 | 2008 | 703 | 0.230 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14665 | 0.220 |
Why?
|
| Povidone-Iodine | 2 | 2020 | 55 | 0.220 |
Why?
|
| Prospective Studies | 19 | 2024 | 54405 | 0.220 |
Why?
|
| Viscosupplements | 2 | 2024 | 21 | 0.220 |
Why?
|
| Phosphorylcholine | 1 | 2023 | 153 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2024 | 36430 | 0.210 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 1682 | 0.210 |
Why?
|
| Bone Nails | 3 | 2012 | 219 | 0.210 |
Why?
|
| Parents | 2 | 2023 | 3564 | 0.210 |
Why?
|
| Bone Screws | 4 | 2020 | 532 | 0.210 |
Why?
|
| Equipment Failure Analysis | 3 | 2009 | 847 | 0.200 |
Why?
|
| Nanoparticles | 3 | 2024 | 1955 | 0.200 |
Why?
|
| Lamin Type A | 2 | 2020 | 189 | 0.200 |
Why?
|
| Postoperative Care | 3 | 2024 | 1471 | 0.200 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 1879 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2017 | 3429 | 0.200 |
Why?
|
| Femur Head | 2 | 2019 | 297 | 0.200 |
Why?
|
| Anorexia Nervosa | 2 | 2024 | 1361 | 0.200 |
Why?
|
| Knee Joint | 3 | 2022 | 1678 | 0.200 |
Why?
|
| Postoperative Complications | 5 | 2020 | 15647 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 18234 | 0.190 |
Why?
|
| Spinal Fractures | 2 | 2022 | 705 | 0.190 |
Why?
|
| Pravastatin | 3 | 2020 | 392 | 0.190 |
Why?
|
| Hemiplegia | 2 | 2018 | 136 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4927 | 0.190 |
Why?
|
| Retrospective Studies | 28 | 2024 | 80575 | 0.190 |
Why?
|
| Torque | 3 | 2011 | 133 | 0.180 |
Why?
|
| Young Adult | 14 | 2024 | 59196 | 0.180 |
Why?
|
| Stifle | 3 | 2019 | 28 | 0.180 |
Why?
|
| Occipital Bone | 2 | 2020 | 55 | 0.180 |
Why?
|
| Synovial Fluid | 2 | 2024 | 395 | 0.180 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2022 | 327 | 0.180 |
Why?
|
| Hardness Tests | 2 | 2017 | 9 | 0.180 |
Why?
|
| Piperidines | 4 | 2020 | 1657 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2273 | 0.170 |
Why?
|
| Water | 2 | 2024 | 1410 | 0.170 |
Why?
|
| Porphyromonas gingivalis | 1 | 2000 | 162 | 0.170 |
Why?
|
| Contracture | 1 | 2022 | 235 | 0.170 |
Why?
|
| Static Electricity | 2 | 2011 | 261 | 0.170 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2020 | 96 | 0.170 |
Why?
|
| Synchrotrons | 1 | 2019 | 39 | 0.170 |
Why?
|
| Aftercare | 2 | 2023 | 913 | 0.170 |
Why?
|
| Standard of Care | 1 | 2023 | 550 | 0.160 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 292 | 0.160 |
Why?
|
| Glycerol | 1 | 2020 | 274 | 0.160 |
Why?
|
| Lung Volume Measurements | 2 | 2018 | 375 | 0.160 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 332 | 0.160 |
Why?
|
| Biocompatible Materials | 5 | 2018 | 1689 | 0.160 |
Why?
|
| Joint Instability | 4 | 2021 | 801 | 0.160 |
Why?
|
| Hip Fractures | 1 | 2007 | 988 | 0.150 |
Why?
|
| Internal Fixators | 2 | 2018 | 183 | 0.150 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 291 | 0.150 |
Why?
|
| Joint Diseases | 1 | 2022 | 459 | 0.150 |
Why?
|
| Length of Stay | 4 | 2022 | 6422 | 0.150 |
Why?
|
| Arthroplasty | 1 | 2020 | 313 | 0.150 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 312 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2021 | 1813 | 0.150 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 176 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2019 | 2523 | 0.140 |
Why?
|
| Alveolar Bone Loss | 1 | 2000 | 390 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2017 | 5877 | 0.140 |
Why?
|
| Decompression, Surgical | 2 | 2020 | 608 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2021 | 553 | 0.140 |
Why?
|
| Treatment Outcome | 18 | 2021 | 64645 | 0.140 |
Why?
|
| Friction | 2 | 2017 | 59 | 0.140 |
Why?
|
| Health Status | 2 | 2016 | 4075 | 0.140 |
Why?
|
| Pelvis | 2 | 2024 | 732 | 0.140 |
Why?
|
| Pyridines | 4 | 2020 | 2870 | 0.140 |
Why?
|
| Spondylolisthesis | 1 | 2019 | 175 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 841 | 0.140 |
Why?
|
| Fractures, Open | 1 | 2018 | 105 | 0.140 |
Why?
|
| Bone Density Conservation Agents | 2 | 2024 | 795 | 0.140 |
Why?
|
| Thumb | 1 | 2018 | 232 | 0.140 |
Why?
|
| Radius Fractures | 2 | 2005 | 514 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 15262 | 0.140 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 235 | 0.140 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2017 | 115 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2024 | 1034 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 636 | 0.130 |
Why?
|
| Odontoid Process | 1 | 2016 | 46 | 0.130 |
Why?
|
| Traction | 1 | 2016 | 110 | 0.130 |
Why?
|
| Dependent Ambulation | 1 | 2015 | 11 | 0.130 |
Why?
|
| Osteomyelitis | 1 | 2020 | 407 | 0.130 |
Why?
|
| Fibroins | 2 | 2006 | 57 | 0.130 |
Why?
|
| Polyethylene Glycols | 3 | 2010 | 1188 | 0.130 |
Why?
|
| Extracellular Fluid | 1 | 2017 | 165 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2019 | 683 | 0.130 |
Why?
|
| Brain Stem | 2 | 2016 | 858 | 0.130 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39108 | 0.120 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 58946 | 0.120 |
Why?
|
| Thorax | 2 | 2010 | 555 | 0.120 |
Why?
|
| Silk | 2 | 2006 | 90 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2019 | 474 | 0.120 |
Why?
|
| Hydrogels | 3 | 2016 | 721 | 0.120 |
Why?
|
| Tissue Engineering | 5 | 2017 | 1872 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 997 | 0.120 |
Why?
|
| Vibration | 1 | 2016 | 328 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2010 | 343 | 0.120 |
Why?
|
| Age Factors | 5 | 2021 | 18401 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 2206 | 0.120 |
Why?
|
| Orthopedic Equipment | 1 | 2014 | 22 | 0.120 |
Why?
|
| Off-Label Use | 2 | 2014 | 185 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2020 | 8632 | 0.110 |
Why?
|
| Fibula | 2 | 2015 | 266 | 0.110 |
Why?
|
| Uncertainty | 2 | 2022 | 754 | 0.110 |
Why?
|
| Prostheses and Implants | 4 | 2022 | 1272 | 0.110 |
Why?
|
| Age of Onset | 3 | 2015 | 3303 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2017 | 512 | 0.110 |
Why?
|
| Calcification, Physiologic | 2 | 2021 | 170 | 0.110 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 640 | 0.110 |
Why?
|
| Nephrectomy | 2 | 2009 | 936 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.110 |
Why?
|
| Motor Skills | 1 | 2016 | 520 | 0.110 |
Why?
|
| Neoplasms | 2 | 2015 | 22158 | 0.110 |
Why?
|
| Aging | 2 | 2020 | 8704 | 0.110 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 71 | 0.100 |
Why?
|
| Patient Discharge | 2 | 2023 | 3438 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2019 | 1264 | 0.100 |
Why?
|
| Diffusion | 1 | 2014 | 814 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1406 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1499 | 0.100 |
Why?
|
| Mentors | 1 | 2017 | 660 | 0.100 |
Why?
|
| Middle Aged | 22 | 2019 | 220774 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2017 | 2265 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2020 | 1817 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 3356 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2022 | 41440 | 0.100 |
Why?
|
| External Fixators | 2 | 2005 | 97 | 0.100 |
Why?
|
| Collagen | 3 | 2023 | 2638 | 0.100 |
Why?
|
| Fractures, Closed | 2 | 2018 | 88 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.100 |
Why?
|
| Adult | 18 | 2019 | 221122 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2016 | 636 | 0.090 |
Why?
|
| Reoperation | 3 | 2019 | 4302 | 0.090 |
Why?
|
| Fingers | 1 | 2014 | 507 | 0.090 |
Why?
|
| Aged | 21 | 2019 | 169179 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 361 | 0.090 |
Why?
|
| Equipment Design | 2 | 2009 | 3510 | 0.090 |
Why?
|
| Triiodobenzoic Acids | 1 | 2010 | 123 | 0.090 |
Why?
|
| Linear Models | 3 | 2015 | 5871 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 1410 | 0.090 |
Why?
|
| Calcinosis | 1 | 2019 | 1469 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1179 | 0.090 |
Why?
|
| Focus Groups | 1 | 2016 | 1414 | 0.090 |
Why?
|
| Risk | 4 | 2020 | 9605 | 0.090 |
Why?
|
| Sheep | 2 | 2024 | 1440 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2015 | 2281 | 0.090 |
Why?
|
| Surface Properties | 3 | 2023 | 1160 | 0.080 |
Why?
|
| Osteogenesis | 3 | 2006 | 1273 | 0.080 |
Why?
|
| Joints | 2 | 2022 | 321 | 0.080 |
Why?
|
| Extremities | 1 | 2015 | 867 | 0.080 |
Why?
|
| Risk Factors | 9 | 2020 | 74152 | 0.080 |
Why?
|
| Methylene Blue | 1 | 2009 | 155 | 0.080 |
Why?
|
| Peptides | 3 | 2010 | 4342 | 0.080 |
Why?
|
| Osteochondritis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Range of Motion, Articular | 3 | 2022 | 1586 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 629 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2018 | 6236 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2009 | 6341 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12059 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2016 | 23981 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2015 | 1642 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 546 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2022 | 582 | 0.080 |
Why?
|
| Bone Substitutes | 2 | 2015 | 236 | 0.080 |
Why?
|
| Hospitalization | 3 | 2017 | 10715 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15835 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2416 | 0.070 |
Why?
|
| Organ Size | 2 | 2010 | 2252 | 0.070 |
Why?
|
| Hindlimb | 2 | 2007 | 512 | 0.070 |
Why?
|
| Phenazines | 2 | 2019 | 56 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 26108 | 0.070 |
Why?
|
| Cartilage | 2 | 2022 | 806 | 0.070 |
Why?
|
| Decamethonium Compounds | 1 | 2006 | 7 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2009 | 555 | 0.070 |
Why?
|
| Hardness | 2 | 2017 | 35 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2008 | 131 | 0.070 |
Why?
|
| Carbamates | 1 | 2008 | 191 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1866 | 0.070 |
Why?
|
| Consensus | 3 | 2024 | 3122 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2010 | 367 | 0.070 |
Why?
|
| Hindlimb Suspension | 1 | 2006 | 75 | 0.070 |
Why?
|
| Species Specificity | 2 | 2021 | 2419 | 0.070 |
Why?
|
| Angioedema | 1 | 2008 | 192 | 0.070 |
Why?
|
| Physical Examination | 2 | 2023 | 1254 | 0.070 |
Why?
|
| Pliability | 1 | 2006 | 58 | 0.070 |
Why?
|
| Biofilms | 1 | 2010 | 627 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2010 | 1084 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7439 | 0.060 |
Why?
|
| Epiphyses, Slipped | 1 | 2006 | 87 | 0.060 |
Why?
|
| Torsion Abnormality | 1 | 2006 | 91 | 0.060 |
Why?
|
| Brain | 3 | 2020 | 27103 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 686 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2010 | 1459 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6473 | 0.060 |
Why?
|
| Ulna | 1 | 2006 | 134 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 1726 | 0.060 |
Why?
|
| Benzamides | 1 | 2010 | 1370 | 0.060 |
Why?
|
| Infant | 8 | 2021 | 36202 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2006 | 982 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
| Rats, Nude | 1 | 2024 | 105 | 0.060 |
Why?
|
| Incidence | 3 | 2020 | 21336 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2010 | 6231 | 0.060 |
Why?
|
| Chickens | 1 | 2006 | 858 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3796 | 0.060 |
Why?
|
| Knee Injuries | 3 | 2018 | 491 | 0.060 |
Why?
|
| Platelet-Rich Plasma | 1 | 2007 | 178 | 0.060 |
Why?
|
| Goats | 1 | 2024 | 167 | 0.060 |
Why?
|
| Osteomalacia | 1 | 2024 | 60 | 0.060 |
Why?
|
| Casts, Surgical | 1 | 2005 | 183 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 1959 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1344 | 0.060 |
Why?
|
| Humerus | 1 | 2006 | 272 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22124 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2006 | 270 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 1115 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2004 | 531 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3594 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2016 | 10075 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1222 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2020 | 1435 | 0.050 |
Why?
|
| Disease Management | 3 | 2018 | 2504 | 0.050 |
Why?
|
| Massachusetts | 1 | 2016 | 8837 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 14025 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3531 | 0.050 |
Why?
|
| Phosphorus | 1 | 2023 | 336 | 0.050 |
Why?
|
| Bioreactors | 1 | 2004 | 247 | 0.050 |
Why?
|
| Pain | 2 | 2024 | 5077 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 7389 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 809 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 64 | 0.050 |
Why?
|
| Lumbosacral Plexus | 1 | 2022 | 51 | 0.050 |
Why?
|
| Joint Capsule | 1 | 2022 | 68 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2004 | 239 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2004 | 338 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2024 | 8997 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 985 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 771 | 0.050 |
Why?
|
| Forecasting | 2 | 2014 | 2928 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3710 | 0.050 |
Why?
|
| United States | 4 | 2017 | 72317 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2010 | 4063 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2006 | 653 | 0.050 |
Why?
|
| Elasticity | 2 | 2018 | 655 | 0.050 |
Why?
|
| Baclofen | 1 | 2022 | 120 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2022 | 317 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2020 | 1571 | 0.050 |
Why?
|
| Prevotella intermedia | 1 | 2000 | 17 | 0.050 |
Why?
|
| Deep Brain Stimulation | 1 | 2009 | 832 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1517 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3419 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12450 | 0.050 |
Why?
|
| Logistic Models | 4 | 2019 | 13251 | 0.050 |
Why?
|
| Skull | 1 | 2005 | 818 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 14597 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10760 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2006 | 1330 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2024 | 482 | 0.050 |
Why?
|
| Dental Scaling | 1 | 2000 | 107 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 102 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2023 | 803 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2024 | 846 | 0.040 |
Why?
|
| Sialoglycoproteins | 3 | 2006 | 315 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3393 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2024 | 352 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 20092 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 2016 | 941 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17872 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 10203 | 0.040 |
Why?
|
| Dental Plaque | 1 | 2000 | 209 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3768 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11070 | 0.040 |
Why?
|
| Reflex | 1 | 1981 | 376 | 0.040 |
Why?
|
| Speech Disorders | 1 | 2020 | 180 | 0.040 |
Why?
|
| Resuscitation | 2 | 1981 | 673 | 0.040 |
Why?
|
| Osteopontin | 3 | 2006 | 301 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2020 | 138 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 22154 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
| Wound Healing | 2 | 2008 | 2802 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5247 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3839 | 0.040 |
Why?
|
| Trapezium Bone | 1 | 2018 | 33 | 0.040 |
Why?
|
| Doxycycline | 1 | 2000 | 344 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 2421 | 0.040 |
Why?
|
| Stem Cells | 2 | 2022 | 3521 | 0.040 |
Why?
|
| Prognosis | 4 | 2016 | 29588 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2020 | 247 | 0.040 |
Why?
|
| Time Factors | 4 | 2020 | 39974 | 0.040 |
Why?
|
| Gait | 1 | 2003 | 816 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4908 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2020 | 597 | 0.040 |
Why?
|
| Skull Fractures | 3 | 2006 | 202 | 0.040 |
Why?
|
| Swine | 2 | 2024 | 5915 | 0.040 |
Why?
|
| Seizures | 2 | 2020 | 2956 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2399 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2020 | 432 | 0.040 |
Why?
|
| Bone Plates | 1 | 2020 | 465 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2019 | 293 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2001 | 338 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 282 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 292 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 222 | 0.040 |
Why?
|
| Registries | 2 | 2024 | 8223 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12329 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 21009 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 671 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2024 | 1732 | 0.030 |
Why?
|
| Porosity | 2 | 2008 | 350 | 0.030 |
Why?
|
| Bed Rest | 1 | 2016 | 83 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2019 | 559 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2018 | 1158 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2020 | 766 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2017 | 298 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2016 | 69 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 81474 | 0.030 |
Why?
|
| Trypsin | 1 | 2017 | 496 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 1922 | 0.030 |
Why?
|
| Touch Perception | 1 | 2017 | 107 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5794 | 0.030 |
Why?
|
| Perception | 1 | 2023 | 1197 | 0.030 |
Why?
|
| Asthma | 1 | 2015 | 6210 | 0.030 |
Why?
|
| Macrophages | 1 | 2011 | 5768 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2019 | 532 | 0.030 |
Why?
|
| Adipose Tissue | 2 | 2024 | 3310 | 0.030 |
Why?
|
| Computers | 1 | 2018 | 596 | 0.030 |
Why?
|
| Periodontitis | 1 | 2000 | 562 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 539 | 0.030 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2005 | 23 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 503 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 1155 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7872 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 1205 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10431 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2048 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2000 | 1155 | 0.030 |
Why?
|
| Hospitals | 2 | 2023 | 3878 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 2853 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 722 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 1118 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1996 | 306 | 0.030 |
Why?
|
| Orbital Fractures | 1 | 1996 | 109 | 0.030 |
Why?
|
| Biomimetics | 1 | 2016 | 172 | 0.030 |
Why?
|
| Arthroscopy | 1 | 2021 | 971 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 536 | 0.030 |
Why?
|
| Calcium | 2 | 2019 | 5726 | 0.030 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 2071 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2008 | 5078 | 0.030 |
Why?
|
| Sodium Fluoride | 1 | 2013 | 65 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 936 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1299 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3806 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 1899 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 636 | 0.030 |
Why?
|
| Hand | 1 | 2018 | 902 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1200 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1226 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2021 | 4013 | 0.030 |
Why?
|
| Motor Activity | 1 | 2003 | 2710 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 796 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1878 | 0.030 |
Why?
|
| Marketing of Health Services | 1 | 2014 | 150 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 1006 | 0.030 |
Why?
|
| Polymerization | 1 | 2013 | 157 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2019 | 1802 | 0.030 |
Why?
|
| Device Approval | 1 | 2014 | 163 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1974 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2020 | 1201 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2014 | 194 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1337 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 4760 | 0.020 |
Why?
|
| Rheology | 1 | 2013 | 348 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 866 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1737 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 432 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 12122 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1981 | 1514 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2389 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2024 | 3413 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1633 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1409 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 126 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2188 | 0.020 |
Why?
|
| Brain Abscess | 1 | 1971 | 120 | 0.020 |
Why?
|
| Popliteal Artery | 1 | 1992 | 310 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2010 | 124 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 70 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 572 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 253 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 2115 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2015 | 928 | 0.020 |
Why?
|
| Ethics, Medical | 2 | 2014 | 783 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 1975 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 363 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 452 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2062 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 135 | 0.020 |
Why?
|
| Vomiting | 1 | 2012 | 652 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2223 | 0.020 |
Why?
|
| Language | 1 | 2018 | 1539 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 876 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2015 | 7954 | 0.020 |
Why?
|
| Informed Consent | 2 | 2014 | 1008 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2000 | 9639 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2115 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2605 | 0.020 |
Why?
|
| Peptide Library | 1 | 2009 | 347 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 152 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 823 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2018 | 3057 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 991 | 0.020 |
Why?
|
| Patient Admission | 1 | 2015 | 1367 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 16966 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9534 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3064 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 2242 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3572 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9319 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 545 | 0.020 |
Why?
|
| Durapatite | 1 | 2008 | 163 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 307 | 0.020 |
Why?
|
| Iodine | 1 | 2009 | 288 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 650 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10551 | 0.020 |
Why?
|
| Minerals | 1 | 2008 | 283 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 1349 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2006 | 200 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 2642 | 0.020 |
Why?
|
| Adsorption | 1 | 2006 | 197 | 0.020 |
Why?
|
| Bombyx | 1 | 2006 | 58 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
| Drug Implants | 1 | 2006 | 230 | 0.020 |
Why?
|
| Body Water | 1 | 2007 | 340 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2426 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2790 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 2090 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 2006 | 99 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 723 | 0.020 |
Why?
|
| Diarrhea | 1 | 2012 | 1319 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2696 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7390 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 818 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1665 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1551 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1987 | 253 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2009 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 840 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 158 | 0.020 |
Why?
|
| Materials Testing | 1 | 2008 | 864 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1737 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 1570 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2005 | 421 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2004 | 73 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4850 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8526 | 0.010 |
Why?
|
| Acute Disease | 1 | 2015 | 7238 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15599 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1385 | 0.010 |
Why?
|
| Cell Differentiation | 3 | 2006 | 11531 | 0.010 |
Why?
|
| Atrophy | 1 | 1988 | 1632 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1987 | 723 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13500 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2006 | 1033 | 0.010 |
Why?
|
| Light | 1 | 2008 | 1351 | 0.010 |
Why?
|
| Weight Gain | 1 | 2012 | 2346 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2017 | 6626 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16603 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 366 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1985 | 395 | 0.010 |
Why?
|
| Protons | 1 | 2007 | 1115 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 1981 | 62 | 0.010 |
Why?
|
| Shivering | 1 | 1980 | 12 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7824 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3687 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1988 | 1088 | 0.010 |
Why?
|
| Blinking | 1 | 1981 | 133 | 0.010 |
Why?
|
| Cicatrix | 1 | 2007 | 798 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10764 | 0.010 |
Why?
|
| Myoclonus | 1 | 1980 | 107 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1668 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6019 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1988 | 6224 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2012 | 3243 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 3603 | 0.010 |
Why?
|
| Cervical Atlas | 1 | 1978 | 22 | 0.010 |
Why?
|
| Microfluidics | 1 | 2004 | 653 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2004 | 18962 | 0.010 |
Why?
|
| Artifacts | 1 | 2007 | 1910 | 0.010 |
Why?
|
| Eye Movements | 1 | 1981 | 511 | 0.010 |
Why?
|
| Mentally Ill Persons | 1 | 1977 | 128 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4466 | 0.010 |
Why?
|
| Maxillary Fractures | 1 | 1996 | 21 | 0.010 |
Why?
|
| Zygomatic Fractures | 1 | 1996 | 35 | 0.010 |
Why?
|
| Ethmoid Bone | 1 | 1996 | 35 | 0.010 |
Why?
|
| Nasal Bone | 1 | 1996 | 57 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 30044 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1988 | 7045 | 0.010 |
Why?
|
| Consciousness | 1 | 1980 | 601 | 0.010 |
Why?
|
| Physicians | 1 | 2013 | 4591 | 0.010 |
Why?
|
| Orbit | 1 | 1996 | 457 | 0.010 |
Why?
|
| Pulse | 1 | 1992 | 219 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7597 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1977 | 880 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1992 | 592 | 0.010 |
Why?
|
| Aneurysm | 1 | 1992 | 337 | 0.010 |
Why?
|
| Unconsciousness | 1 | 1971 | 250 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1992 | 1097 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 2001 | 3597 | 0.000 |
Why?
|
| Foot | 1 | 1992 | 575 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1988 | 6839 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1992 | 748 | 0.000 |
Why?
|
| Angiography | 1 | 1992 | 1599 | 0.000 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 807 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1971 | 1281 | 0.000 |
Why?
|
| Bone Cements | 1 | 1985 | 325 | 0.000 |
Why?
|
| Dementia | 1 | 1977 | 2686 | 0.000 |
Why?
|
| Paternalism | 1 | 1977 | 47 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 339 | 0.000 |
Why?
|
| Social Values | 1 | 1977 | 225 | 0.000 |
Why?
|
| Personal Autonomy | 1 | 1977 | 304 | 0.000 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1977 | 495 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3577 | 0.000 |
Why?
|